REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Budafoki Szentlelek Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Budafoki Szentlelek Gyogyszertari Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Budafoki Szentlelek Bt. is based in Hungary. The head office is in Budapest. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on October 16, 1995. It currently has a total number of 6 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 7.78% in 2023. A growth of 7.82% was recorded in its total assets. In 2023, Budafoki Szentlelek Bt.’s net profit margin increased by 1.37%.

Headquarters
Kaldor Adolf utca 3-5.
Budapest; Budapest; Postal Code: 1221

Contact Details: Purchase the Budafoki Szentlelek Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Budafoki Szentlelek Bt. report to view the information.
Outstanding Shares:
Purchase the Budafoki Szentlelek Bt. report to view the information.
Registered Capital:
Purchase the Budafoki Szentlelek Bt. report to view the information.
Financial Auditors:
Purchase the Budafoki Szentlelek Bt. report to view the information.
Incorporation Date:
October 16, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Budafoki Szentlelek Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.78%▲
Total operating revenue
7.71%▲
Operating profit (EBIT)
24.46%▲
EBITDA
21.4%▲
Net Profit (Loss) for the Period
31.03%▲
Total assets
7.82%▲
Total equity
30.95%▲
Operating Profit Margin (ROS)
1.08%▲
Net Profit Margin
1.37%▲
Return on Equity (ROE)
0.06%▲
Quick Ratio
0.22%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo